Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: Comparison with the standard staging procedures

European Journal of Nuclear Medicine

Volumn 28, Issue 3, 2001, Pages 351-358

  Schirrmeister, H ^a   Kuhn T ^a   Guhlmann, A ^a   Santjohanser, C ^a   Horster T ^a   Nussle K ^a   Koretz, K ^a   Glatting, G ^a   Rieber, A ^a   Kreienberg, R ^a   Buck, A C ^a   Reske, S N ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Breast cancer; Positron emission tomography; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; SCINTILLATION CAMERA;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LYMPH NODES; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; RADIOPHARMACEUTICALS; REFERENCE VALUES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 20244364368     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590000448     Document Type: Article

References (34)

1. Recent trends in breast cancer incidence, mortality, and mammography
2. Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET
3. In vivo comparison of PET and SPECT radiopharmaceuticals in detecting breast cancer
4. Metabolic characterisation of breast tumors with positron emission tomography using F-18 deoxyglucose
5. Breast imaging with fluorine-18-FDG PET: Quantitative image analysis
6. Positron emission tomography of breast masses: Comparison with clinical, mammographic and pathological findings
7. 18F]-D-glucose
8. 18F]FDG positron emission tomography in primary breast cancer: Clinical relevance and practicability
9. Axillary lymph node metastases: Screening with [F-18] 2-de-oxy-2-fluoro-D-glucose (FDG) PET
10. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radolabeled 2-(fluorine-18)-deoxy-2-fluoroD-glucose
11. Prospective evaluation of fluorine-18-FDG-PET in preoperative staging of the axilla in breast cancer
12. Prospective evaluation of fluorine-18 deoxyglucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immuno-cytochemistry
13. The potential of 2-deoxy-2[fluoro]-D-glucose (FDG) for the detection of tumor involvement in lymph nodes
14. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma
15. Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer
16. 18FDG PET: Differing metabolic activity in osteoblastic and osteolytic lesions
17. Whole-body positron emission tomography in clinical oncology: Comparison between attenuation-corrected and uncorrected images
18. Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in primary staging of malignant lymphoma
19. Breast cancer
20. Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06
21. Tumor development, histology and grade of breast cancers: Prognosis and progression
22. Breast carcinoma: Effect of preoperative contrast-enhanced MR imaging on the therapeutic approach
23. Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial
24. Physical and psychological morbidity after axillary lymph node dissection for breast cancer
25. Inefficacy of internal mammary nodes dissection in breast cancer surgery
26. Sternal resection for primary or secondary tumors
27. Results of surgical treatment for sternal metastasis of breast cancer
28. Clinical signficance of isolated scintigraphic lesions in patients with breast cancer
29. Local failure for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy
30. Prospective study of fluorodeoxyglucose-positron emission tomography in patients undergoing sentinel node biopsy
31. Sentinel node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintgraphy and gamma probe detection
32. Sentinel lymphadenectomy in breast cancer
33. Sentinel lymph node localization in early breast cancer
34. Sentinel node biopsy in breast cancer patients using blue dye guided lymphography